The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
β-Amyloid Accumulation Impairs Multivesicular Body Sorting by Inhibiting the Ubiquitin-Proteasome System
Open accessAbstract
Increasing evidence links intraneuronal β-amyloid (Aβ 42 ) accumulation with the pathogenesis of Alzheimer’s disease (AD). In Aβ precursor protein (APP) mutant transgenic mice and in human AD brain, progressive intraneuronal accumulation of Aβ 42 occurs especially in multivesicular bodies (MVBs). We hypothesized that this impairs the MVB sorting pathway. We used the trafficking of the epidermal growth factor receptor (EGFR) and TrkB receptor to investigate the MVB sorting pathway in cultured neurons. We report that, during EGF stimulation, APP mutant neurons demonstrated impaired inactivation, degradation, and ubiquitination of EGFR. EGFR degradation is dependent on translocation from MVB outer to inner membranes, which is regulated by the ubiquitin-proteasome system (UPS). We provide evidence that Aβ accumulation in APP mutant neurons inhibits the activities of the proteasome and deubiquitinating enzymes. These data suggest a mechanism whereby Aβ accumulation in neurons impairs the MVB sorting pathway via the UPS in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In this model, Ab accumulates along the endosomal/lysomal pathway that leads to dysfunction of multivesicular bodies, causing impairment of the ubiquitin-proteasome system, 9 which also controls the fate of NMDARs undergoing endocytic vesicular trafficking.50”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [9]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These cultures are characterized by progressive buildup of intraneuronal Ab, which is derived from endogenous Ab escaping exocytosis after cleavage of the APP SW mutant.9,49”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A number of studies have associated intraneuronal Ab buildup with hyperphosphorylation of tau protein, 8 disturbed protein trafficking and sorting, 9 reduced expression of synaptic proteins, 10 and mitochondrial dysfunction.11,12”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [9]
In the citing paper
“In one study, Aβ-induced abnormalities in MVB endocytic sorting were demonstrated in APP mutant neurons, which appeared to be due to impairment of the ubiquitin proteasome system (UPS; [2]).”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [2]
In the citing paper
“The study went on to provide evidence that abnormalities in MVB sorting were due to Aβ-dependent alterations in the ubiquitin-proteasome system (UPS).”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [2]
In the citing paper
“Using the well established endocytosis of the epidermal growth factor receptor (EGFR), this study demonstrated that specifically the MVB sorting pathway, and not internalization or the recycling pathway, was altered in Aβ accumulating neurons.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Regulation of NMDA receptor trafficking by amyloid-β
Snyder, E. M., Nong, Y., Almeida, C. G., Paul, S., Moran, T., Choi, E. Y., Nairn, A. C., Salter, M. W., Lombroso, P. J., Gouras, G. K., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1503 · Cited by 1,561
Self-citationMukherjee, S., Ghosh, R. K., & Maxfield, F. R. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.759 · Cited by 1,299
Receptor downregulation and multivesicular-body sorting
Katzmann, D. J., Odorizzi, G., & Emr, S. D. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm973 · Cited by 1,201
Intraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991
Self-citationActivity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system
Ehlers, M. D. (2003) · Nature Neuroscience · doi:10.1038/nn1013 · Cited by 977
The Rab5 effector EEA1 is a core component of endosome docking
Christoforidis, S., McBride, H. M., Burgoyne, R. D., & Zerial, M. (1999) · Nature · doi:10.1038/17618 · Cited by 854
Impaired Proteasome Function in Alzheimer's Disease
Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848
Evidence that production and release of amyloid beta-protein involves the endocytic pathway
Koo, E. H., & Squazzo, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32449-3 · Cited by 829
Research works printed but not linked: 1
- (2005), Methods Mol Biol, 301, 207
Cited by
Sorted by citations
Items 101–200 of 316
The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration
Deger, J. M., Gerson, J. E., & Kayed, R. (2015) · Aging Cell · doi:10.1111/acel.12359 · Cited by 69
Omtri, R. S., Davidson, M. W., Arumugam, B., Poduslo, J. F., & Kandimalla, K. K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200530q · Cited by 69
Amyloid-β Peptide Is a Substrate of the Human 20S Proteasome
Zhao, X., & Yang, J. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100067e · Cited by 68
The consequences of mitochondrial amyloid β-peptide in Alzheimer's disease
Muirhead, K. E. A., Borger, E., Aitken, L., Conway, S. J., & Gunn‐Moore, F. J. (2010) · Biochemical Journal · doi:10.1042/bj20091941 · Cited by 68
Guglielmotto, M., Monteleone, D., Boido, M., Piras, A., Giliberto, L., Borghi, R., Vercelli, A., Fornaro, M., Tabaton, M., & Tamagno, E. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00854.x · Cited by 67
Contribution of the Presenilins in the cell biology, structure and function of γ-secretase
Escamilla‐Ayala, A., Wouters, R., Sannerud, R., & Annaert, W. G. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.02.005 · Cited by 71
Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
Perdigão, C., Barata, M. A., Araújo, M. N. C. D. F., Mirfakhar, F. S., Castanheira, J., & Almeida, C. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00072 · Cited by 66
Self-citationKim, S., Cho, Y.-S., Kim, Y., Park, J., Yoo, S., Gwak, J., Kim, Y., Gwon, Y., Kam, T., & Jung, Y. (2023) · Autophagy · doi:10.1080/15548627.2023.2181614 · Cited by 65
Membrane Localization of β-Amyloid 1–42 in Lysosomes
Liu, R., Zhou, Q., Ji, S., Zhou, Q., Feng, D., Wu, Y., & Sui, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.036798 · Cited by 64
Oxidative stress and aging: Learning from yeast lessons
Eleuthério, E. C. A., Brasil, A. D. A., França, M. B., de Almeida, D. S. G., Rona, G. B., & Magalhães, R. S. S. (2017) · Fungal Biology · doi:10.1016/j.funbio.2017.12.003 · Cited by 64
Perturbations of Ubiquitin-Proteasome-Mediated Proteolysis in Aging and Alzheimer’s Disease
Hegde, A. N., Smith, S. G., Duke, L. M., Pourquoi, A., & Vaz, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00324 · Cited by 63
Chocrón, E. S., Munkácsy, E., Kim, H. S., Karpowicz, P., Jiang, N., Skike, C. E. V., DeRosa, N., Banh, A. Q., Palavicini, J. P., Wityk, P., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk2252 · Cited by 62
Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin
Sakono, M., Zako, T., Ueda, H., Yohda, M., & Maeda, M. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06727.x · Cited by 64
Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin
Fischer, D. F., van Dijk, R., van Tijn, P., Hobo, B., Verhage, M. C., van der Schors, R. C., Li, K. W., van Minnen, J., Hol, E. M., & van Leeuwen, F. W. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.06.009 · Cited by 61
Sörgjerd, K. M., Zako, T., Sakono, M., Stirling, P. C., Leroux, M. R., Saito, T., Nilsson, P., Sekimoto, M., Saido, T. C., & Maeda, M. (2013) · Biochemistry · doi:10.1021/bi301705c · Cited by 61
Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways
Bellia, F., Lanza, V., García‐Viñuales, S., Ahmed, I. M. M., Pietropaolo, A., Iacobucci, C., Malgieri, G., D’Abrosca, G., Fattorusso, R., Nicoletti, V. G., et al. (2019) · Chemical Science · doi:10.1039/c8sc03394c · Cited by 60
Takahashi, R. H., Capetillo‐Zarate, E., Lin, M. T. S., Milner, T. A., & Gouras, G. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0051965 · Cited by 62
Self-citationSingh, A. K., & Pati, U. (2015) · Aging Cell · doi:10.1111/acel.12335 · Cited by 59
Synaptic vesicle cycle and amyloid β: Biting the hand that feeds
Ovsepian, S. V., O’Leary, V. B., Záborszky, L., Ntziachristos, V., & Dolly, J. O. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.011 · Cited by 57
Upregulation of APP endocytosis by neuronal aging drives amyloid-dependent synapse loss
Burrinha, T., Martinsson, I., Gomes, R., Terrasso, A. P., Gouras, G. K., & Almeida, C. G. (2021) · Journal of Cell Science · doi:10.1242/jcs.255752 · Cited by 64
Self-citationSpencer, B. J., Desplats, P., Overk, C., Valera, E., Rissman, R. A., Wu, C., Mante, M., Adame, A., Florio, J. B., Rockenstein, E. M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0775-16.2016 · Cited by 56
Cutler, P., Akuffo, E. L., Bodnar, W. M., Briggs, D. M., Davis, J. B., Debouck, C. M., Fox, S. M., Gibson, R. A., Gormley, D. A., Holbrook, J. D., et al. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780101 · Cited by 55
The potential roles of deubiquitinating enzymes in brain diseases
Lim, K., Joo, J., & Baek, K. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101088 · Cited by 59
Synapses, synaptic activity and intraneuronal Aβ in Alzheimer’s disease
Tampellini, D. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00013 · Cited by 58
Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer’s disease
Kam, T., Gwon, Y., & Jung, Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1706-0 · Cited by 59
Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer’s Disease Mouse Model
Hartz, A. M. S., Zhong, Y., Shen, A. N., Abner, E. L., & Bauer, B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00186 · Cited by 54
Mechanisms of AMPA Receptor Endosomal Sorting
Parkinson, G. T., & Hanley, J. G. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00440 · Cited by 57
Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model
McMillan, L. E., Brown, J. T., Henley, J. M., & Cimarosti, H. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.045 · Cited by 53
Novel amyloid-beta pathology C. elegans model reveals distinct neurons as seeds of pathogenicity
Gallrein, C., Iburg, M., Michelberger, T., Koçak, A., Puchkov, D., Liu, F., Ayala, S., Nayak, T., Schierle, G. S. K., & Kirstein, J. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101907 · Cited by 54
Park, H., Hundley, F. V., Yu, Q., Overmyer, K. A., Brademan, D. R., Serrano, L. R., Paulo, J. A., Paoli, J. C., Swarup, S., Coon, J. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33881-x · Cited by 52
Current understanding of metal-dependent amyloid-β aggregation and toxicity
Yi, Y., & Lim, M. H. (2022) · RSC Chemical Biology · doi:10.1039/d2cb00208f · Cited by 50
Caetano, F. A., Dirk, B. S., Tam, J. H. K., Cavanagh, P. C., Goiko, M., Ferguson, S. S. G., Pasternak, S., Dikeakos, J. D., de Bruyn, J. R., & Heit, B. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004634 · Cited by 50
IL-1β impairs retrograde flow of BDNF signaling by attenuating endosome trafficking
Carlos, A. J., Tong, L., Prieto, G. A., & Cotman, C. W. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0803-z · Cited by 52
Impact of late-onset Alzheimer’s genetic risk factors on beta-amyloid endocytic production
Almeida, C. G., Mirfakhar, F. S., Perdigão, C., & Burrinha, T. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2825-9 · Cited by 53
Self-citationChristensen, D. Z., Bayer, T. A., & Wirths, O. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.014 · Cited by 47
Role of Intracellular Amyloid β as Pathway Modulator, Biomarker, and Therapy Target
Villarejo, L. G., Bachmann, L., Marks, D., Brachthäuser, M., Geidies, A., & Müller, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094656 · Cited by 48
Proteasome Subunits Involved in Neurodegenerative Diseases
Fernández-Cruz, I., & Reynaud, E. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.09.007 · Cited by 52
Bottero, V., & Potashkin, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215403 · Cited by 47
Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
Wells, C., Brennan, S. E., Keon, M., & Saksena, N. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00271 · Cited by 46
Li, A., Xie, Z., Dong, Y., McKay, K. M., McKee, M. L., & Tanzi, R. E. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm219 · Cited by 46
Alzheimer’s as a Systems-Level Disease Involving the Interplay of Multiple Cellular Networks
Castrillo, J. I., & Oliver, S. G. (2016) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2627-5_1 · Cited by 44
The Bri2 and Bri3 BRICHOS Domains Interact Differently with Aβ 42 and Alzheimer Amyloid Plaques
Dolfe, L., Tambaro, S., Tigro, H., del Campo, M., Hoozemans, J. J. M., Wiehager, B., Graff, C., Winblad, B. G., Ankarcrona, M., Kaldmäe, M., et al. (2018) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-170051 · Cited by 44
Lipid-Induced β-Amyloid Peptide Assemblage Fragmentation
Widenbrant, M. J. O., Rajadas, J., Sutardja, C., & Fuller, G. G. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.085944 · Cited by 44
Misframed ubiquitin and impaired protein quality control: an early event in Alzheimer’s disease
Gentier, R. J. G., & van Leeuwen, F. W. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00047 · Cited by 46
Gillardon, F., Kloß, A., Berg, M., Neumann, M., Mechtler, K., Hengerer, B., & Dahlmann, B. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04438.x · Cited by 43
Momtaz, S., Memariani, Z., El‐Senduny, F. F., Sanadgol, N., Golab, F., Katebi, M., Abdolghaffari, A. H., Farzaei, M. H., & Abdollahi, M. R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00361 · Cited by 46
McIntosh, P. B., Martin, S. R., Jackson, D. J., Khan, J., Isaacson, E. R., Calder, L. J., Raj, K., Griffin, H. M., Wang, Q., Laskey, P., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00509-08 · Cited by 44
Impaired β-Amyloid Secretion in Alzheimer's Disease Pathogenesis
Tampellini, D., Rahman, N., Lin, M. T. S., Capetillo‐Zarate, E., & Gouras, G. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2986-11.2011 · Cited by 41
Self-citationThe Proteasome in Health and Disease
Jankowska, E., Stoj, J., Karpowicz, P., Osmulski, P. A., & Gaczynska, M. E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161281906141012124358 · Cited by 43
Madadi, S., Schwarzenbach, H., Saidijam, M., Mahjub, R., & Soleimani, M. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0354-3 · Cited by 41
Intracellular Amyloid β-Protein As a Therapeutic Target for Treating Alzheimers Disease
Ohyagi, Y. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898514 · Cited by 42
Gouras, G. K., Willén, K., & Tampellini, D. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.06.004 · Cited by 39
Self-citationvan Tijn, P., Dennissen, F. J. A., Gentier, R. J. G., Hobo, B., Hermes, D., Steinbusch, H. W. M., Van Leeuwen, F. W., & Fischer, D. F. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.007 · Cited by 39
Saito, R., Kaneko, M., Kitamura, Y., Takata, K., Kawada, K., Okuma, Y., & Nomura, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094576 · Cited by 39
Ovsepian, S. V., Antyborzec, I., O’Leary, V. B., Záborszky, L., Herms, J. W., & Dolly, J. O. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0583-x · Cited by 40
Alzheimer's Disease: Tau Pathology and Dysfunction of Endocytosis
Ando, K., Houben, S., Homa, M., de Fisenne, M.-A., Potier, M., Erneux, C., Brion, J., & Leroy, K. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.583755 · Cited by 42
Failure of Ubiquitin Proteasome System: Risk for Neurodegenerative Diseases
Chen, Z., Geetha, T., & Babu, J. R. (2014) · Neurodegenerative Diseases · doi:10.1159/000367694 · Cited by 42
Post-translational modifications in neurodegeneration
Didonna, A., & Benetti, F. (2015) · AIMS Biophysics · doi:10.3934/biophy.2016.1.27 · Cited by 36
Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils
Siddiqi, M. K., Malik, S., Majid, N., Alam, P., & Khan, R. H. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.06.001 · Cited by 38
Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome
Botté, A., Lainé, J., Xicota, L., Heiligenstein, X., Fontaine, G., Kasri, A., Rivals, I., Goh, P. A., Faklaris, O., Cossec, J., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00956-z · Cited by 35
Wang, N., Wang, E., Wang, R., Muhammad, F., Li, T., Yue, J., Zhou, Y., Zhi, D., & Li, H. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.12.004 · Cited by 40
Perdigão, C., Barata, M. A., Burrinha, T., & Almeida, C. G. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101056 · Cited by 33
Self-citationMartinsson, I., Quintino, L., Garcia, M. G., Konings, S. C., Torres-Garcia, L., Svanbergsson, A., Stange, O., England, R., Deierborg, T., Li, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.946297 · Cited by 35
Self-citationTakahashi, R. H., Tobiume, M., Sato, Y., Sata, T., Gouras, G. K., & Takahashi, H. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2010.01158.x · Cited by 36
Self-citationThe neuronal ubiquitin-proteasome system: Murine models and their neurological phenotype
van Tijn, P., Hol, E. M., van Leeuwen, F. W., & Fischer, D. F. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.03.001 · Cited by 35
Ribeiro, F. C., Cozachenco, D., Heimfarth, L., Fortuna, J. T. S., de Freitas, G. B., de Sousa, J. M., Alves‐Leon, S. V., Leite, R. E. P., Suemoto, C. K., Grinberg, L. T., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-05511-9 · Cited by 34
Role of Striatal-Enriched Tyrosine Phosphatase in Neuronal Function
Kamceva, M., Benedict, J., Nairn, A. C., & Lombroso, P. J. (2016) · Neural Plasticity · doi:10.1155/2016/8136925 · Cited by 33
Nair, S., Traini, M. D., Dawes, I. W., & Perrone, G. G. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-04-0216 · Cited by 32
Rabzelj, S., Viero, G., Gutiérrez‐Aguirre, I., Türk, V., Serra, M. D., Anderluh, G., & Žerovnik, E. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06390.x · Cited by 32
Synthesized Aβ42 Caused Intracellular Oxidative Damage, Leading to Cell Death, via Lysosome Rupture
Oku, Y., Murakami, K., Irie, K., Hoseki, J., & Sakai, Y. (2017) · Cell Structure and Function · doi:10.1247/csf.17006 · Cited by 29
Dysfunction of the ubiquitin–proteasome system in the cerebellum of aging Ts65Dn mice
Necchi, D., Lomoio, S., & Scherini, E. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.009 · Cited by 29
Striatal-Enriched Protein Tyrosine Phosphatase in Alzheimer’s Disease
Xu, J., Kurup, P. K., Nairn, A. C., & Lombroso, P. J. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00009-x · Cited by 29
Henry, L., Fabre, C., Guiraud, I., Bastide, S., Fabbro-Péray, P., Martínez, J., Lavabre‐Bertrand, T., Meunier, L., & Stoebner, P. (2012) · International Journal of Cancer · doi:10.1002/ijc.27991 · Cited by 28
Vulin, M., Zhong, Y., Maloney, B. J., Bauer, B., & Hartz, A. M. S. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00470-z · Cited by 28
Person‐specific differences in ubiquitin‐proteasome mediated proteostasis in human neurons
Hsieh, Y., Augur, Z. M., Arbery, M. R., Ashour, N., Barrett, K., Pearse, R. V., Tio, E. S., Duong, D. M., Felsky, D., Jager, P. L. D., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13680 · Cited by 26
Sjödin, S., Hansson, O., Öhrfelt, A., Brinkmalm, G., Zetterberg, H., Brinkmalm, A., & Blennow, K. (2017) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201700100 · Cited by 26
Endosomal‐lysosomal dysfunctions in Alzheimer’s disease: Pathogenesis and therapeutic interventions
Lai, S. S. M., Ng, K. Y., Koh, R. Y., Chok, K. C., & Chye, S. M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00737-0 · Cited by 31
Wang, L., Liang, B., & Zhong, Y. (2013) · Protein & Cell · doi:10.1007/s13238-013-3043-8 · Cited by 27
Amritraj, A., Hawkes, C. A., Phinney, A. L., Mount, H. T. J., Scott, C. D., Westaway, D. A., & Kar, S. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.004 · Cited by 26
da Rocha, J. F., Bastos, L., Domingues, S. C., Bento, A. R., Konietzko, U., Silva, O. A. B. D. C. E., & Vieira, S. I. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02139-2 · Cited by 29
Lalwani, A. K., Krishnan, K., Bagabir, S. A., Alkhanani, M., Almalki, A. H., Haque, S., Sharma, S. K., Singh, R. K. B., & Malik, M. Z. (2022) · Biomolecules · doi:10.3390/biom12030451 · Cited by 25
Volloch, V., & Rits‐Volloch, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512246 · Cited by 29
Latina, V., Caioli, S., Zona, C., Ciotti, M. T., Borreca, A., Calissano, P., & Amadoro, G. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00487 · Cited by 26
Intraneuronal Aβ Accumulation, Amyloid Plaques, and Synapse Pathology in Alzheimer’s Disease
Capetillo‐Zarate, E., Gracia, L., Tampellini, D., & Gouras, G. K. (2012) · Neurodegenerative Diseases · doi:10.1159/000334762 · Cited by 25
Self-citationBécot, A., Volgers, C., & van Niel, G. (2020) · Biomedicines · doi:10.3390/biomedicines8080272 · Cited by 25
Yeast as a Model for Alzheimer’s Disease: Latest Studies and Advanced Strategies
Verduyckt, M., Vignaud, H., Bynens, T., den Brande, J. V., Franssens, V., Cullin, C., & Winderickx, J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_11 · Cited by 24
Marcora, M. S., Belfiori-Carrasco, L. F., Bocai, N. I., Morelli, L., & Castaño, E. M. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.012 · Cited by 25
Hegde, A. N., Duke, L. M., Timm, L. E., & Nobles, H. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_5 · Cited by 25
Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications
Lauterbach, E. C., Shillcutt, S. D., Victoroff, J., Coburn, K. L., & Mendez, M. F. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.2.130 · Cited by 22
Volloch, V., Olsen, B. R., & Rits‐Volloch, S. (2019) · Annals of Integrative Molecular Medicine · doi:10.33597/aimm.02-1007 · Cited by 23
Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer’s Disease
Bhatia, S., Singh, M., Singh, T., & Singh, V. (2023) · Neurochemical Research · doi:10.1007/s11064-022-03722-w · Cited by 22
Antonino, M., Marmo, P., Freites, C. L., Quassollo, G., Sánchez, M. F., Lorenzo, A., & Bignante, E. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.852738 · Cited by 24
The Amyloid Cascade Hypothesis 2.0: Generalization of the Concept
Volloch, V., & Rits‐Volloch, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220079 · Cited by 22
Profiling of Alzheimer’s disease related genes in mild to moderate vitamin D hypovitaminosis
Grimm, M. O. W., Lauer, A. A., Grösgen, S., Thiel, A., Lehmann, J., Winkler, J., Janitschke, D., Herr, C., Beißwenger, C., Bals, R., et al. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.015 · Cited by 22
Mahaman, Y. A. R., Huang, F., Embaye, K. S., Wang, X., & Zhu, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.680118 · Cited by 22
Singh, S. J., Tandon, A., Phoolmala, Srivastava, T., Singh, N., Goyal, S., Priya, S., & Chaturvedi, R. K. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03249-3 · Cited by 26
Lipids Nutrients in Parkinson and Alzheimer’s Diseases: Cell Death and Cytoprotection
Nury, T., Lizard, G., & Véjux, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072501 · Cited by 21
Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Balkhi, S., Spirito, A. D., Poggi, A. D., & Mortara, L. (2025) · Cells · doi:10.3390/cells14040264 · Cited by 21
Hou, J., Cui, J., Yu, L., & Zhang, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.07.031 · Cited by 19
Lombroso, P. J., Ogren, M. P., Kurup, P. K., & Nairn, A. C. (2016) · F1000Research · doi:10.12688/f1000research.8571.1 · Cited by 19
Metadata
- Authors
- Almeida, C. G., Takahashi, R. H., & Gouras, G. K.
- Affiliations
- Cornell University (US)
- Corresponding author
- Gouras, Gunnar K.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-04-19
- Volume
- 26
- Issue
- 16
- Pages
- 4277-4288
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6673997
- OpenAlex
- W2168538246
- Cited by
- 316
- References
- 59
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 11 · 2023: 26 · 2022: 18 · 2021: 12 · 2020: 17 · 2019: 20 · 2018: 14 · 2017: 15 · 2016: 14 · 2015: 15 · 2014: 10 · 2013: 20 · 2012: 18
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Alzheimer's Association
- American Health Assistance Foundation
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke (R01NS045677, NS 045677)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- amyloid-beta deposition, multivesicular bodies, ubiquitin-proteasome system, Alzheimer's disease, epidermal growth factor receptor, TrkB receptor, receptor degradation, ubiquitination, deubiquitinase, proteasome inhibition
- MeSH terms
- Animals, Cells, Cultured, Epidermal Growth Factor, Hippocampus, Humans, Male, Mice, Transgenic, Synaptic Vesicles, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Rats, Sprague-Dawley, Ubiquitin, Proteasome Endopeptidase Complex, Mice, Rats, Proteasome Inhibitors, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
